The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Open accessAbstract
BACKGROUND: Because parathyroid hormone increases both bone formation and bone resorption, it is possible that combining parathyroid hormone with an antiresorptive agent will enhance its effect on bone mineral density. METHODS: We randomly assigned 83 men who were 46 to 85 years of age and had low bone density to receive alendronate (10 mg daily; 28 men), parathyroid hormone (40 microg subcutaneously daily; 27 men), or both (28 men). Alendronate therapy was given for 30 months; parathyroid hormone therapy was begun at month 6. The bone mineral density of the lumbar spine, proximal femur, radial shaft, and total body was measured every six months with the use of dual-energy x-ray absorptiometry. Trabecular bone mineral density of the lumbar spine was measured at base line and month 30 by means of quantitative computed tomography. Serum alkaline phosphatase levels were measured every six months. The primary end point was the rate of change in the bone mineral density at the posteroanterior spine. RESULTS: The bone mineral density at the lumbar spine increased significantly more in men treated with parathyroid hormone alone than in those in the other groups (P<0.001 for both comparisons). The bone mineral density at the femoral neck increased significantly more in the parathyroid hormone group than in the alendronate group (P<0.001) or the combination-therapy group (P=0.01). The bone mineral density of the lumbar spine increased significantly more in the combination-therapy group than in the alendronate group (P<0.001). At 12 months, changes in the serum alkaline phosphatase level were significantly greater in the parathyroid hormone group than in the alendronate group or the combination-therapy group (P<0.001 for both comparisons). CONCLUSIONS: Alendronate impairs the ability of parathyroid hormone to increase the bone mineral density at the lumbar spine and the femoral neck in men. This effect may be attributable to an attenuation of parathyroid hormone-induced stimulation of bone formation by alendronate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Self-citationBlack, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-486_3 · Cited by 2,056
(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Alendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Orwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., Kaufman, J.-M., Clancy, A., & Gaich, G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.9 · Cited by 776
Lindsay, R., Nieves, J., Formica, C., Henneman, E., Woelfert, L., Shen, V., Dempster, D., & Cosman, F. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02342-8 · Cited by 749
Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Canalis, E., Centrella, M., Burch, W., & McCarthy, T. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113885 · Cited by 543
Hock, J. M., & Gera, I. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070110 · Cited by 367
Body, J.-J., Gaich, G. A., Scheele, W. H., Kulkarni, P. M., Miller, P. D., Peretz, A., Dore, R. K., Correa-Rotter, R., Papaioannou, A., Cumming, D. C., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020334 · Cited by 365
Kurland, E. S., Cosman, F., McMahon, D. J., Rosen, C. J., Lindsay, R., & Bilezikian, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6818 · Cited by 360
Dr. Slovik, D. M., Rosenthal, D. I., Doppelt, S. H., Potts, J. T., Daly, M. A., Campbell, J. A., & Neer, R. M. (1986) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650010411 · Cited by 348
Self-citationMCCARTHY, T. L., CENTRELLA, M., & CANALIS, E. (1989) · Endocrinology · doi:10.1210/endo-124-3-1247 · Cited by 336
Wronski, T. J. (1993) · Endocrinology · doi:10.1210/en.132.2.823 · Cited by 290
Activation of the bone-derived latent TGF beta complex by isolated osteoclasts
Oreffo, R. O. C., Mundy, G. R., Seyedin, S. M., & Bonewald, L. F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92795-2 · Cited by 285
Kurland, E. S. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3069 · Cited by 282
Melton, L. J. (1999) · Osteoporosis in Men · doi:10.1016/b978-012528640-4/50002-2 · Cited by 271
Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency
Finkelstein, J. S., Klibanski, A., Schaefer, E. H., Hornstein, M. D., Schiff, I., & Neer, R. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412153312404 · Cited by 245
Self-citationHodsman, A. B., Fraher, L. J., Watson, P. H., Ostbye, T., Stitt, L. W., Adachi, J. D., Taves, D. H., & Drost, D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3762 · Cited by 194
Delmas, P. D., Vergnaud, P., Arlot, M. E., Pastoureau, P., Meunier, P. J., & Nilssen, M. H. L. (1995) · Bone · doi:10.1016/8756-3282(95)00113-r · Cited by 171
Finkelstein, J. S., Klibanski, A., Arnold, A. L., Toth, T. L., Hornstein, M. D., & Neer, R. M. (1998) · JAMA · doi:10.1001/jama.280.12.1067 · Cited by 166
Self-citationHodsman, A. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.620 · Cited by 144
Ringe, J. D., Faber, H., & Dorst, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7988 · Cited by 137
Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo
Hock, J. M., Hummert, J. R., Boyce, R. W., Fonseca, J., & Raisz, L. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040321 · Cited by 130
Total Body Bone Mineral Density in Young Children: Influence of Head Bone Mineral Density
Taylor, A., Konrad, P. T., Norman, M. E., & Harcke, H. T. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.652 · Cited by 114
Alendronate Does Not Block the Anabolic Effect of PTH in Postmenopausal Osteoporotic Women
Cosman, F., Nieves, J. W., Woelfert, L., Shen, V., & Lindsay, R. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.1051 · Cited by 114
Hodsman, A. B., Steer, B. M., Fraher, L. J., & Drost, D. J. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90103-7 · Cited by 101
Baumann, B. D., & Wronski, T. J. (1995) · Bone · doi:10.1016/8756-3282(94)00036-y · Cited by 97
Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol
Neer, M., Slovik, D. M., Daly, M., POTTS, T. M., & Nussbaum, S. R. (1993) · Osteoporosis International · doi:10.1007/bf01621907 · Cited by 94
Ma, Y. L., Bryant, H. U., Zeng, Q., Schmidt, A., Hoover, J. L., Cole, H. W., Yao, W., Jee, W. S. S., & Sato, M. (2003) · Endocrinology · doi:10.1210/en.2002-221061 · Cited by 91
Arnaud, C. D., Roe, E. B., Sanchez, S., del Puerto, G. A., Pierni, E., Bachetti, P., & Cann, C. F. (2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)82061-5 · Cited by 68
Biochemical Markers in the Assessment of Bone Disease
Bikle, D. D. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00137-x · Cited by 67
Quantitative Computed Tomography for Spinal Density Measurement Factors Affecting Precision
Rosenthal, D. I., Ganott, M. A., Wyshak, G., Slovik, D. M., Doppelt, S. H., & Neer, R. M. (1985) · Investigative Radiology · doi:10.1097/00004424-198505000-00014 · Cited by 67
Self-citationOsteoporosis in men : the effects of gender on skeletal health
ORWOLL, E. S., Bilezikian, J. P., & Vanderschueren, D. (2010) · Cited by 48
Cited by
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Bisphosphonates: Mechanism of action and role in clinical practice
Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
Metadata
- Authors
- Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-09-25
- Volume
- 349
- Issue
- 13
- Pages
- 1216-1226
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2013599591
- Cited by
- 829
- References
- 38
- FWCI
- 72.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.